Decision Guide for Assisted Reproduction in Thailand: Suitable Candidates for Dr. Thitikorn and When to Seek Treatment

Instructions for Use: This document is a patient-facing decision aid designed to help you assess whether your specific health concerns align with the expertise and scope of practice of certain types of physicians. It does not constitute medical advice, nor does it replace in-person consultations, second opinions, or evaluations by accredited institutions. All information regarding physician qualifications, success rates, costs, surgical indications, and scheduling should be verified directly with the hospital or the physician before your visit.

Key Takeaways

Dr. Thitikorn Wanichkul, the founder and Medical Director of 101 Bangkok IVF, offers core differentiated value through his dual expertise as an obstetrician-gynecologist specialistReproductive EndocrinologyBackground of Specialist Training and AdvancedGynecological LaparoscopySurgical competence, enabling independent completion of the full diagnostic and treatment process encompassing "gynecological lesion management–endocrine regulation–assisted reproduction," suitable for patients with concurrent gynecological organic diseases,Recurrent implantation failureofComplex infertilityCase example: For young individuals with unexplained infertility and no underlying medical conditions, the marginal benefit of specialist care is limited, so prioritizing specialist consultation is not necessary. All treatment plans and physician information must be verified through an in-person consultation; this text serves solely as a reference for decision-making.

For patients planning to travel to Thailand for assisted reproductive treatment, the core logic in selecting a doctor is not "the more titles, the better," but rather "whether your specific medical concerns align precisely with this doctor's core areas of expertise." This article does not simply list expert credentials; instead, it provides a practical decision-making tool to help you assess whether Dr. Thidgorn Wanichakul's clinical approach matches your needs, what specific issues he can address, and in which situations he may not be the preferred choice.

1. First, identify: The core target audience of this article

If you fall into any of the following categories, this decision-making reference will be highly valuable to you:

• Infertile patients who have experienced one or more failed embryo implantations without a clearly identified cause of failure;

• Infertile women diagnosed with organic gynecological diseases, including endometriosis, uterine fibroids, ovarian cysts, and hydrosalpinx;

• Women aged 35 or older with diminished ovarian reserve who are planning pregnancy and require an individualized ovulation induction protocol

• We hope that the same physician can lead both "gynecological lesion management" and "assisted reproductive treatment," thereby reducing the need for patients to navigate between different departments or institutions.

• Individuals with endocrine disorders such as polycystic ovary syndrome (PCOS) and ovulatory dysfunction who have poor responses to conventional ovulation induction;

• There isFertility PreservationPatients with concurrent gynecological underlying conditions who require prior assessment of the impact of the lesion.

Reverse note: If you are a young patient with normal ovarian function, infertility solely due to male factors or tubal factors, and no underlying gynecological conditions, this physician’s expertise in managing complex cases may represent “redundant capability” for your needs. A standard, reputable reproductive center is typically sufficient, and there is no need to pay higher costs solely for “specialist capabilities.” The final decision should still be based on a comprehensive assessment of laboratory facilities, costs, convenience, and an in-person consultation.

II. Core Decision Criteria: Three Key Differences Between Him and Ordinary IVF Doctors

Assisted Reproductive Technology in ThailandThe field has many physicians. Dr. Tidigong’s differentiating strength lies in the fact that he does not focus solely on ovarian stimulation and embryo transfer procedures, but instead covers the entire continuum of care, from gynecological lesion management and endocrine regulation to assisted reproductive treatment. The following three aspects are key areas for patients to verify during their initial consultation.

Specialized interdisciplinary background: capable of independently managing the full continuum of care, including lesion surgery, endocrine regulation, and fertility assistance

The core competencies of most doctors at Thai reproductive centers are concentrated in ovulation induction, egg retrieval, and embryo transfer. If patients present with comorbidities such as uterine fibroids, endometriosis, or hydrosalpinx, they often require referral to gynecologic surgeons. Discrepancies in clinical assessment and treatment plan coordination between the two physicians may arise, potentially prolonging the diagnostic and therapeutic timeline.

Based on publicly available professional credentials, Dr. Thidigon holds a subspecialty certification in Obstetrics and Gynecology from the Royal Thai College of Obstetricians and Gynaecologists, completed fellowship training in Reproductive Endocrinology and Infertility at Emory University School of Medicine in the United States, and obtained advanced laparoscopic and laser surgery certification from the Chattanooga Women’s Laser Center in the United States.Minimally invasive gynecological surgery, and a composite capability in reproductive endocrine regulation and assisted reproductive care. This enables him to independently manage the full-cycle treatment pathway—from lesion diagnosis and minimally invasive surgical intervention, through postoperative recovery assessment, endocrine regulation, ovulation induction and fertility support, to embryo transfer—thereby reducing discrepancies in clinical judgment among different physicians and minimizing patients’ time and communication costs associated with repeated visits or referrals. For infertile patients with concurrent gynecological conditions, this integrated expertise typically delivers greater practical value than proficiency in IVF technology alone.

Public records indicate that he previously served as the head of the Endometriosis Clinic at Phramongkutklao Hospital, with extensive expertise in the diagnosis and treatment of endometriosis. For specific details on his academic publications, it is recommended to verify directly with the physician during a consultation. During your visit, we also suggest verifying additional information: his registration status with the Medical Council of Thailand, the scope of privileges for gynecological endoscopic surgery, experience in managing complications, and whether he personally performs complex surgeries.

Assess the lesions before assisting conception: improve the reproductive environment at its root, rather than following an assembly-line approach to ovulation induction

Many institutions in the industry follow a conventional approach: "Proceed to the stimulation cycle as soon as possible and secure embryos first." However, for patients with endometriosis, uterine cavity abnormalities, or chronic pelvic inflammatory disease, the "soil environment" of the pelvis and uterine cavity may itself be compromised. Even with high-quality embryos, the risks of implantation failure and early miscarriage may increase.

Dr. Tidigong’s core clinical philosophy prioritizes the evaluation and intervention of primary gynecological pathologies: using minimally invasive techniques to treat endometriotic lesions, remove fibroids that affect the uterine cavity, and resolve hydrosalpinx, thereby optimizing the reproductive environment of the pelvis and uterine cavity before initiating assisted reproductive therapy.

The treatment cycle for this approach may be 1–3 months longer than that of "direct ovarian stimulation," but it theoretically reduces the likelihood of recurrent implantation failure by addressing its root causes. It is particularly suitable for patients who have experienced multiple failed embryo transfers without a clear underlying cause—some occult pelvic issues may require identification and management by reproductive specialists who also possess surgical expertise.

Note that surgery is not mandatory for all cases. For mild endometriosis or small fibroids with no significant symptoms and no impact on the uterine cavity, surgery may not substantially improve pregnancy rates and could instead delay the start of an IVF cycle. Ovarian cystectomy for chocolate cysts (endometriomas) risks damaging the ovarian cortex, further reducing already diminished ovarian reserve; thus, a careful risk-benefit assessment is essential for older patients or those with low AMH levels. Surgery offers limited improvement for diffuse adenomyosis, and subsequent pregnancies carry a risk of uterine rupture, requiring individualized evaluation. Additionally, if recurrent implantation failure has been clearly attributed to embryonic chromosomal abnormalities, the core solution is preimplantation genetic testing (PGT), the value of surgical intervention for pelvic conditions is limited. The necessity of surgery, the use of laparoscopy, and the timing of starting treatment cycles postoperatively should all be assessed on an individualized basis and should not be rigidly standardized.

Full-Process Hands-On Clinical Control: Reducing Deviations in Assembly-Line Treatment Plans

Dr. Tidigong has management experience in reproductive centers and surgical centers at Thai public hospitals, having served as [position] at Phyathai 2 HospitalLaparoscopic surgeryThe center director and IVF center director has experience supervising specialty residents. After founding 101 Bangkok IVF, public information indicates that he personally oversees all core clinical procedures: from initial assessment, formulation and dynamic adjustment of ovarian stimulation protocols, to egg retrieval and embryo transfer surgeries, which are led by him rather than delegated to junior physicians.

For elderly patients, those with poor ovarian response, or those with complex medical conditions, fluctuations in hormone levels and follicular development during ovarian stimulation require real-time adjustments to treatment protocols based on the physician’s clinical experience. In-person consultations throughout the entire process help minimize protocol deviations and improve oocyte quality and embryo usability. It is recommended to verify: who performs each key step—initial consultation, monitoring during stimulation, egg retrieval, and embryo transfer; what backup plans are in place if the primary physician is temporarily unavailable, including the qualifications of substitute physicians; and the staffing and operational standards for the laboratory and embryology team.

III. Precise Matching: Five Highly Suitable Groups and Non-Priority Groups

5 Priority Groups to Consider for Consultation

Population with repeated implantation failureIf you have experienced two or more failed transfers of high-quality embryos, and known issues such as embryonic chromosomal abnormalities and clear intrauterine adhesions have been ruled out, there may be underlying conditions like occult endometriosis or pelvic inflammatory disease that are difficult to detect via routine ultrasound. Dr. Tidigon can perform diagnostic laparoscopy combined with simultaneous treatment, followed by assisted reproductive procedures, making him a preferred option for consultation in such cases. However, laparoscopy is not routinely required for all patients with recurrent implantation failure; the decision should be based on a comprehensive assessment of symptoms, imaging findings, previous surgical history, and embryo quality.

Infertile patients with concurrent organic gynecological diseasesThis includes patients with endometriosis (chocolate cysts, adenomyosis), uterine fibroids (especially submucosal or intramural fibroids that affect the uterine cavity shape), ovarian cysts, and hydrosalpinx or tubal occlusion. He can integrate minimally invasive surgery with assisted reproductive technology within the same treatment cycle, reducing the cost of switching between gynecology and reproductive medicine departments; however, the necessity of surgery and potential risks of ovarian damage must be assessed concurrently.

Advanced age with diminished ovarian reserveFor patients aged 38 or older with AMH <1.2 ng/ml and elevated basal FSH, the window for ovarian stimulation is narrow and protocol flexibility is low. His background in reproductive endocrinology and ability to make dynamic adjustments throughout the treatment cycle may help tailor protocols such as minimal stimulation or natural cycles to individual ovarian responses, thereby maximizing oocyte quality per cycle. If significant gynecological lesions are also present, the additional impact of surgery on ovarian reserve must be carefully weighed. The aforementioned thresholds are for reference only and should not be applied rigidly.

Infertility caused by reproductive endocrine disordersConditions such as polycystic ovary syndrome, luteal phase deficiency, diminished ovarian reserve, and ovulation disorders are often fundamentally associated with endocrine imbalances. He can initiate foundational interventions by focusing on hormonal regulation and metabolic improvement, rather than relying solely on ovulation-inducing drugs to forcibly stimulate egg release. This approach may reduce the risk of ovarian hyperstimulation syndrome and potentially improve egg quality. Specific treatment plans must be tailored based on individual hormone levels and metabolic indicators.

Individuals with fertility preservation needs who also have underlying gynecological conditionsIf you planEgg freezing...or frozen embryos, while also having uterine fibroids, endometriomas, or other issues. He can assess the impact of these lesions before fertility preservation and, if necessary, perform minimally invasive treatment first to prevent gynecological conditions from progressing and affecting subsequent ovarian function and reproductive plans.

Groups that do not need to be prioritized

• Age under 30, normal ovarian function, and no underlying gynecological diseases

• Infertility caused solely by male oligoasthenozoospermia, with the female partner in good health.

• Only standard second-generation IVF (ICSI) is required, with no complex comorbidities.

For this group of patients, choosing a reputable, large-scale reproductive center typically yields stable treatment outcomes without the need to pay higher costs for additional specialized expertise. If they still prefer to select this particular physician, they should focus on comparing laboratory conditions, cost transparency, and convenience of care.

IV. Treatment Expectations: How His Clinical Process Differs from Standard IVF

If you decide to consult Dr. Tidigon, you need to first understand the differences between his treatment pathway and conventional assembly-line IVF, and be mentally and temporally prepared:

The initial visit focuses on a comprehensive assessment, with no rush to begin the treatment cycle.At the first visit, ovulation induction medications are typically not prescribed directly. Instead, a fertility assessment is completed first (including six hormone panels, AMH testing, transvaginal ultrasound, and uterine cavity evaluation), while simultaneously screening for occult gynecological lesions that may affect pregnancy. If clear issues are identified, a treatment plan for these lesions is provided first, rather than proceeding directly to an ovulation induction cycle.

The timing between surgery and assisted reproductive technology should be individualized.If laparoscopic or hysteroscopic surgery is required, the postoperative recovery assessment and timing for initiating a stimulation cycle should be determined by the operating surgeon. Typically, ovarian stimulation can begin 1–3 months after surgery; however, the exact timing depends on the type of procedure, the extent of the lesions, and the patient’s recovery status. The long-term impact of surgery on ovarian function and the uterine environment should also be evaluated to avoid excessive delays or premature initiation of the stimulation cycle, which could compromise treatment outcomes.

Dynamic Adjustment of Ovarian Stimulation ProtocolsDuring ovarian stimulation, medication dosages and protocols are adjusted in real time based on each hormone monitoring result and follicular development status, rather than maintaining a fixed dosage until egg retrieval. This approach is particularly suitable for patients with unstable ovarian responses. Patients should confirm the frequency of monitoring, the criteria for adjustments, and the contingency plan for cycle cancellation.

Pre-Transfer Reassessment of the Uterine Cavity EnvironmentBefore embryo transfer, the uterine cavity and endometrial status will be re-evaluated to ensure that conditions meet the required standards before scheduling the transfer, thereby reducing implantation failure due to environmental factors. Specific reassessment items, criteria, and costs should be confirmed in advance.

V. Objective Trade-offs: Practical Factors to Consider Before Making a Choice

To help you make more rational decisions, the following practical issues require careful consideration:

The treatment cycle may be longerBecause the approach follows the principle of "assessing lesions before assisted reproduction," if your gynecological condition requires surgical intervention, the overall treatment cycle may be 1–3 months longer than that of direct ovulation induction. However, for patients with repeated failures, this strategy may save more time overall compared to undergoing multiple failed embryo transfers and then addressing the underlying lesions afterward. It also increases risks associated with surgery and anesthesia, which must be carefully weighed.

The cost-effectiveness may be low for simple cases.His core value lies in managing complex comorbidities. If you have a simple case of infertility, the marginal benefit of choosing him may not be high, and you might consider prioritizing more cost-effective standard clinics.

In-person consultations are limited and require advance booking.As I personally lead all core procedures, my monthly patient capacity is limited. Before traveling to Thailand for treatment, please submit your previous medical reports in advance to complete the initial evaluation and secure an appointment, avoiding last-minute scheduling conflicts.

Risks of cross-border medical treatment must be assessed by the individual: including fee transparency, follow-up for complications, language communication, embryo storage duration, legal and ethical requirements, visa and itinerary arrangements, etc. It is recommended to request a written itemized cost list, refund policies for canceled cycles, and emergency contact plans.

Legal and Rights Protection CostsMedical disputes in Thailand are governed by the local legal system. Cross-border rights protection involves lengthy timelines and high costs for evidence collection and communication, with relatively limited avenues for remedy in cases of medical controversies or complications. It is advisable to familiarize yourself in advance with the hospital's complaint and dispute resolution procedures.

Postoperative Follow-up CoordinationIf complications such as infection or abnormal bleeding occur after surgery, it is necessary to confirm in advance who will lead the post-operative follow-up and subsequent intervention plans upon returning home, and whether any domestic partner medical institutions provide coordinated follow-up care, to avoid gaps in post-operative management.

VI. Quick Decision Checklist (For Direct Self-Review)

You can self-check against the following criteria. If you meet two or more, Dr. Tidigong may be considered a highly suitable consultation candidate; however, an in-person consultation and verification of credentials are still required:

• □ At least one prior embryo transfer failure with no identified cause

• □ Confirmed diagnosis of gynecological diseases such as endometriosis, uterine fibroids, ovarian cysts, and hydrosalpinx

• □ Age ≥ 35 years, low AMH, diminished ovarian reserve

• □ Polycystic ovary syndrome (PCOS) or long-term anovulation with poor response to conventional ovulation induction

• □ I prefer that the same doctor handle both the surgery and assisted reproduction throughout the entire process, rather than being referred across different institutions.

• □ Fertility preservation needs with concurrent gynecological conditions

If criteria 0–1 are met, consider starting with a reputable, conventional reproductive center; refer or seek a second opinion only when complex issues arise.

7. Checklist of Questions to Verify Before a Facial Diagnosis

It is recommended to prepare questions in advance according to the following four categories to avoid missing core information:

Qualification and Competency Verification

• What are the doctor’s registration details with the Thai Medical Council, their certification in obstetrics and gynecology, and the scope of their qualification for gynecological endoscopic surgery?

• What are the specific details regarding relevant academic research and paper publications? How can the corresponding relationships be verified?

• Is the complex gynecological surgery performed personally by the attending physician? What is the annual volume of similar surgeries completed? What is the rate of severe complications?

Clinical Workflow and Treatment Plans

• Who performs the initial assessment, ovarian stimulation monitoring, egg retrieval, and embryo transfer? In the event of a physician’s temporary absence, what are the contingency plans and the qualifications of the substitute physicians?

• What is the key criterion for determining whether surgery is necessary? Can I seek a second medical opinion before making a decision?

• If surgery is required, how long after the procedure can ovarian stimulation be initiated? What are the frequency and basis for adjusting the stimulation protocol?

• What items are included in the re-evaluation of the uterine cavity environment prior to embryo transfer? What are the criteria for meeting standards?

Fees and Rules

• What items are included in the cost breakdown for the complete treatment cycle? Which ones are potentially additional charges?

• Cycle cancellation,Embryo cryopreservationWhat are the fee standards and refund policies for thawed embryo transfer?

• What are the maximum storage period, renewal fees, and overdue handling rules for embryo cryopreservation?

Risk and Follow-up

• What are the main risks of surgery and ovarian stimulation related to my condition, and what contingency plans are in place to address them?

• What is the statistical definition of success rate (per egg retrieval cycle, per embryo transfer cycle, or live birth rate)? Is it stratified by age? What is the sample size?

• What is the follow-up schedule after surgery and upon return to home country? What are the emergency contact details and management pathway in case of complications?

• What are the qualifications and staffing levels of the laboratory team and embryologists?

Choosing a reproductive medicine specialist is fundamentally about matching their specific expertise to the particular challenges of your condition. For complex cases involving gynecological comorbidities or recurrent implantation failure, a physician who can address both the underlying pathology and the assisted reproduction execution may offer greater practical value than one who merely promotes high success rate statistics. However, final decisions should be based on credential verification, in-person consultations, second opinions, and risk assessment, rather than on the conclusions of a single article.